Advertisement

 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Home

   News

   Conferences

   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links

advertisement.gif (61x7 -- 0 bytes)

   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

     
 
 

 Headlines:

 
 
 
Last Updated: Jun 12, 2009 - 3:53:09 PM

2008 - American Diabetic Association - 68th Scientific Sessions
   
American Diabetes Association
Jun 7, 2008 - 6:05:29 PM
Email this article
 Printer friendly page
The American Diabetes Association - 68th Annual Meeting was held in San Francisco, June 6 - 10, 2008. The following is a briefing of some of the articles presented at the conference.

ACCORD clinical trial publishes results

A therapeutic strategy targeting blood sugar to near-normal levels does not reduce cardiovascular events but increases mortality in persons with diabetes at high risk.

ACCORD clinical trial website, http://www.accordtrial.org/public/index.cfm

Weight gain may be healthy when it comes to type 1 diabetes

Gaining body fat may be a good thing, at least for people with type 1 diabetes, say researchers at the University of Pittsburgh Graduate School of Public Health. Their study followed 655 patients with type 1 diabetes for 20 years and found that patients who gained weight over time were less likely to die.

Unique drug combination may hold the key to reversing type 1 diabetes

A team of Virginia scientists led by Jerry L. Nadler, M.D., are reporting promising results from a study that tested a novel therapy for reversing type 1 diabetes. The treatment combines a drug that halts the immune damage that causes type 1 diabetes with another drug that stimulates the pancreas to regenerate.

USC study shows belly fat may affect liver function

A study by the University of Southern California suggests the release of lipids from abdominal fat, which drains directly to the liver, increases overnight, providing additional insight as to how abdominal fat is associated with type 2 diabetes risk.

USC study finds fat mass and obesity assoicated genes increased risk of disease in Mexican-Americans

A study from the University of Southern California suggests people of Mexican-American descent who have genetic variants of fat gene FTO and Arachidonate 5-Lipoxygenase (5-LO) had higher triglyceride and lower HDL levels.

USC study established weight gain as main factor in falling beta cell function in Hispanic women

A study by researchers at the University of Southern California found that weight gain was the strongest factor associated with falling beta cell function in Hispanic women, a condition that often leads to diabetes.

Phase 3 results for alogliptin

Results from five pivotal phase 3 studies of alogliptin, which has been shown to be a highly selective inhibitor of dipeptidyl peptidase-4 (DPP-4), were announced at the ADA 68th Scientific Sessions. Alogliptin administered once daily demonstrated statistically significant reductions in HbA1c versus placebo as a monotherapy and as an add-on therapy with the major classes of type 2 diabetes medications.

Having heart surgery? Watch your blood sugar, especially if you're overweight or older

Nearly half of all heart surgery patients may experience blood sugar levels high enough to require temporary insulin treatment after their operation, even though they've never had diabetes, according to a new study. And a significant minority of those patients might need to take medicines for days or even weeks after they leave the hospital, to help their blood sugar levels reach normal again, the researchers show.

IDF urges health care providers to address the relationship between type 2 diabetes and sleep apnea

The International Diabetes Federation warned today that recent research demonstrates that type 2 diabetes and obstructive sleep apnea are closely related, and that both disorders have significant implications on public health and on individuals.

Source:
http://www.scientificsessions.diabetes.org/

 
Top of Page

Email this article
Printer friendly page

advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright 2001-2007 The Doctors Lounge. All rights reserved.